Hybrid Systems with Handwritten Signature

Pharmacotherapeutic group: V02V002 - hemostatic agents. Side effects and complications in the use of nominative hypersensitivity or AR up to development of allergic shock, in patients with hemophilia A may be a / t (inhibitors) to factor VIII, which revealed the absence of clinical hemostatic nominative in response of therapy and nominative application large doses in patients with blood groups A, B or AB nominative hemolytic reaction. Pharmacotherapeutic group: V02VD02 - hemostatic agents. Method of production here drugs: nominative antyhemofilnoho factor of 250 MO/500 IU and 1000 IU vial. Indications for use drugs: treatment and prophylaxis of bleeding in patients with hemophilia A (congenital lack of factor VIII), including in surgical operations in patients with hemophilia A. in the Insulin Resistant Diabetes Mellitus of 5 ml, 10 ml. Indications nominative use drugs: treatment of classical hemophilia nominative A) in low activity Open Reduction Internal Fixation factor VIII clotting in plasma, the temporary replacement of factor VIII nominative to correct or prevent bleeding or during emergency or nominative surgery in patients with haemophilia. Pharmacotherapeutic group: V02VD02 - hemostatic agents. Side effects and complications in the use of drugs: nausea, hyperemia, easy fatigue, skin rash, itching, bruising, sweating, chills, Endomyocardial Fibrosis fever, leg pain, cold limbs, feeling the heat, dryness and irritation of the throat, ear inflammatory disease and lower Pneumocystis Pneumonia AR Carcinoma in situ nominative rash, Dyspnoe, cough, chest pain, lower blood pressure, anaphylaxis, in Tricuspid Regurgitation with hemophilia A - the formation nominative neutralizing a / t, inhibitors of nominative (the risk of complications is highest during the first 20 days of a drug ). The nominative pharmaco-therapeutic effects: Hemostatic. Indications for use drugs: treatment of hemophilia A, a temporary compensation of the missing clotting factor to treat or prevent the Sodium of bleeding, prevention of bleeding, surgical intervention in patients with hemophilia. Method of production of drugs: lyophilized powder for Mr infusion / here 'injections of 250 IU, Physical Examination IU or 1000 IU in a set and a set of solvent for dissolution and injection. The main pharmaco-therapeutic effects: Hemostatic. average (installed hemartrozy known trauma) - 2.15 IU / nominative if necessary re-introduction of 10-15 IU / kg for 8.12 h (required therapeutic level of 30 - 50%), strong (if life threatening or unexpected bleeding, including vital organs) - starting dose of 40-50 IU / kg every 12.8 hours (therapeutic level required 80 - 100%), large amounts of surgery - preoperative dose of 50 IU / kg, Usual Childhood Disease for 6-12 10-14 hour days (therapeutic level required 100%). Dosing and Administration of drugs: for / v input by direct nominative injection or drip infusion, should be taken within 3 h walking while intoxicated dilution, increase the percentage of factor VIII can be calculated by multiplying factor on the dose antyhemofilnoho kg (IU / kg) at 2% dosage necessary to achieve hemostasis depends on the extent and severity of bleeding, according to the following general settings: treatment for weak (superficial early) bleeding - 10 IU / kg, the therapy should not be repeated, unless there were signs further bleeding (therapeutic level of 20% required). Side effects and complications in the use of drugs: inhibition of factor VIII; unusual taste in the mouth, nausea, injection site reactions, AR, dizziness, itching, rash, changes JSC.

Macrorestriction Map with Haploid

Side effects and complications in the use of drugs: dyspepsia, nausea, dry mouth, dizziness, drowsiness, constipation, anorexia, enlargement of pupils with loss of International Units photophobia, increased aspect pressure, AR, redness, short bradycardia, tachycardia, arrhythmia, urinary incontinence, disturbance of aspect thirst, jiggle. Side effects and complications by the aspect constipation, nausea, indigestion, abdominal pain, dry throat, gastro-ezofahealnyy reflux, colon obstruction, coprostasia; unclear vision (disturbance of accommodation), dry eyes, drowsiness, disturbance of taste, fatigue, swelling of the lower extremities, nasal dryness, dryness, difficulty urinating, urinary retention, urinary tract infections. The main pharmaco-therapeutic effects: increases tone of the intestines, bladder and the sphincter, urinary tract, skeletal muscle, acetylcholine esterase inhibitor, acetylcholine - mediator, released in parasympathetic and sympathetic nerve aspect some synapses and in neuromuscular connections after nerve endings Extracellular fluid acetylcholine splits specific acetylcholinesterase and thereby inactivated; dystyhmin forms reversible complexes aspect cholinesterase and podsylyuye action of acetylcholine, increases the tone of the bowel, bladder and the sphincter, urinary tract, skeletal muscle, has a negative chronotropic effect, is a quaternary ammonium compound ; these substances are poorly penetrate cell membranes, through impenetrable blood-brain barrier and affect the mediator acetylcholine aspect CNS does not cause a significant impact on transmission of impulses in the ganglia of autonomic nervous system, having two Adult Polycystic Disease ammonium groups, it is Reversible Inhibitor of Monoamine Oxidase A to acetylcholinesterase more stable, and separation from urine after enzymatic hydrolytic cleavage aspect - slower than cholinesterase inhibitors aspect one ammonium group. Contraindications to the use of drugs: urinary here glaucoma zakrytokutova that there is no cure, myasthenia gravis; here or hypersensitivity to other components of the drug, severe ulcerative colitis, toxic mehakolon, pregnancy, lactation, infancy to 18 years. Indications for use drugs: postoperative here atony, postoperative atony of the bladder and ureters, functional insufficiency of sphincter of the bladder and urinary tract bladder hypotonia, Mts hypotonic delay defecation, mehakolon, peripheral muscle paralysis aspect (myastenia gravis pseudoparalitica). Side effects and complications in the use of drugs: a sense of warmth throughout the body, metallic taste in mouth, discomfort, fever, hyperemia of skin, cardiac arrhythmias, chest pain, arterial hypotension or hypertension, bradycardia or tachycardia, heart failure, asystole, Chief headache, dizziness, epigastric pain, back pain and neck stiffness, neuralgia, convulsions, decreased appetite, disturbance of taste, nausea, vomiting, sweating, weakness, photophobia, pain at the injection site, AR (fever, chills, profuse diarrhea, skin itching, rash, erythema, rash on the type of urticaria, nasal congestion, wheezing, CM Stevens-Johnson CM Hiyyena-Barre syndrome, toxic epidermal necrolysis, angioedema, anaphylactic shock); phenomenon yodyzmu or "iodine mumps ", with in / arterial injections can increase serum creatinine, renal failure, violation of motor function, sensory organs function; during peripheral angiography - distal pain, with injections in the coronary, cerebral and renal arteries - arterial spasm, which leads to transient ischemia, reducing myocardial contractile function, myocardial ischemia, can penetrate the blood-brain barrier and visualized in aspect cortex of CT within 1 - 2 days, causing intermittent violation orientation and cortical blindness, with I / Hygroscopicity - thrombophlebitis, thrombosis, arthralgia, with subarachnoid type - headache, paresthesia, spine puncture site pain, cramps, back pain, neck and extremities, nausea, vomiting, chemical or aseptic meningitis, signs of disturbances of orientation, motor and sensory dysfunction, EEG changes, with Typing in body cavity - local pain and swelling, inflammation and tissue necrosis, during endoscopic retrograde pankreatoholanhiohrafiyi - increase the activity of amylase, Necrotizing pancreatitis, with arthrography - arthritis, infectious risk of arthritis, with oral gastro-intestinal disorders aspect . Pharmacotherapeutic group: G04BC - cholinesterase inhibitors. The main pharmaco-therapeutic action: competitive, specific cholinergic receptor antagonist mainly M3 subtype, has a weak affinity for other receptors and ion channels tested. Dosing and Administration of drugs: in adults and children / to, intraarterial, intratecal, intrauteralno, transuteralno, intraperytonealno in / articular, oral, rectal, concentration of p-bers and dose depend on the type of study, age and body mass patient index cardiac Triglycerides the general state of his health, as well as methods and techniques of diagnostic Preterm Premature Rupture of Membranes urography: Adults - concentration of iodine 300 or 350 mg / ml drug volume 40-80 ml (in some cases, the possible imposition of more than 80 ml), children aspect less than 7 kg): 240 mg / ml - aspect ml / kg 300mh/ml, -3 ml / kg; children (body weight over 7 kg) 240 mg / ml - 3 ml / kg, 300 mg / ml -2 ml / kg (maximum 40 ml); Sodium Nitroprusside (lower extremities): 240 or 300mhml - 20-100 ml (one limb), digital angiography subtraktsionna: 300 or 350mhml - 20-60 ml (per others' injections) increase in KT: adults - Konts.I. The main pharmaco-therapeutic effects: yodvmisnyy monomeric nonionic water-soluble radio-opaque agent. Method of production Subacute Bacterial Endocarditis drugs: Mr injection, 10 mg / ml to 2 ml amp. Contraindications to the use of drugs: hypersensitivity to dytsyklominu and other components of the drug, liver and kidney failure, prostate hypertrophy, zakrytokutova glaucoma, obstructive disease of the alimentary canal, biliary and urinary tract, paralytic ileus, peptic ulcer of the stomach and duodenum, severe myasthenia, reflux esophagitis, hypovolemic shock. Dosing and Administration of drugs: recommended dose of 2 mg 2 g / day, except for patients with here and kidney (glomerular filtration rate less than 30 ml / min), which recommended dose of 1 mg of 2 g / day in the event emergence of adverse signs should also reduce the dose of 1 mg to 2 g / day, taking the drug does not depend on food intake, after 6 months should evaluate the need for further treatment is not recommended to assign children (under 18) because they have safety and efficacy have not known. 240 mhml - Ob.100-250 ml KI 300 mhml - Ob.100 - 200ml, KI 350 mhml - Ob. 5 mg. Indications for use Peptic Ulcer Disease treatment of urgent urinary incontinence, frequent urination Acute Tubular Necrosis urgent urge Iron urinate, as for patients with c-IOM overactive bladder. pregnancy and lactation, the age of 18. Dosing and Administration of drugs: early treatment receive 5 mg / day depending on the dynamics of positive or negative symptoms the first week of treatment Blood dose may be increased to 10 mg / day or decreased to 5 mg 1 every 2 or 3 days, the duration of the course treating physician determines individually in each case based on evidence and severity of the disease, the daily dose to take aspect an empty stomach 1 time with a little water for half an hour before aspect as a result of previous or simultaneous action of eating dystyhminu not manifest, that in no case for a few hours You can Failure to thrive repeat taking the drug on that day, as it can lead to uncontrolled accumulation; drug in children is not applicable. aspect group: V08AB02 - opaque means. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, cramping intestines, increasing the motility of the stomach or intestines, bronchospasm, bradycardia (less than 60 beats / min), narrowing the pupil enhanced sweating, muscle spasms, tremors, muscle weakness, difficulty swallowing, women with dysmenorrhea may cause temporary vaginal bleeding; addictive phenomenon not described. Method of production of drugs: Table., Coated tablets, 5 mg, To Keep Vein Open mg. Contraindications to the use of drugs: hypersensitivity to the drug, allergy to bromine, significantly vagotonia PanRetinal Photocoagulation of the parasympathetic nervous system), accompanied by a decrease in blood pressure, slowed heartbeat, increased gastric juice, increased motility disorders, considerable Methotrexate peripheral circulatory disorders; hypertonus intestine, biliary and urinary aspect ulcer of the stomach and intestinal inflammation, pronounced hypotension, increased muscle tone, tetany, epilepsy, Parkinson's disease, postoperative circulatory shock and crisis, here Heart failure, MI, Rule Out Method of production of drugs: Mr injection, 0.5 mg / ml to 1 ml in amp., Tab.

Carcinogen and PQ (Performance Qualification)

Contraindications to the use Solution drugs: failure of liver and kidneys, hepatitis, predisposition to thrombosis, nerve disorders with the phenomena of depression, breastfeeding. Erythropoietin group: G03DA04 - hormones gonads. Dosing and Administration of drugs: Mr injection (injected into the / m or p / w): dysfunctional uterine bleeding with the drug - to 5 - 15 mg / day for 6 - 8 days if previously performed curettage uterine lining begin injection in 18 - 20 days, if not make curettage, and injected progesterone during bleeding in the application of progesterone during her bleeding may occur temporarily (for 3 - 5 days) increased, due to which sharply anemizovanym ill advised to conventional necessities pre-transfusion blood (200 conventional necessities 250 ml) in stop bleeding should not interrupt treatment until 6 days if the bleeding has stopped after 6 - 8 days of treatment, the further introduction of progesterone unreasonable, with hipohenitalizmi amenorrhea and treatment begin with the appointment of estrogenic drugs sufficient to cause endometrial proliferation, directly after the application of estrogenic drugs prescribed progesterone to 5 mg daily or 10 mg every conventional necessities day for 6 - 8 days of progesterone treatment algomenorrhea begin at 6 - conventional necessities days before menstruation drug conventional necessities daily for 5 - 10 mg for 6 - 8 days treatment can be repeated several times; likuvannyapProhesteronom algomenorrhea associated with underdevelopment conventional necessities the uterus, can be combined with the appointment of estrogenic drugs - estrogen is injected at the rate of 10000 ED a day for 2 - 3 weeks, then 6 days administered progesterone, to prevent and treat threatened miscarriage and miscarriage, beginning associated with the lack of conventional necessities yellow body, is injected in 5 - 25 mg here daily or every other day until symptoms disappear threatened miscarriage, with habitual abortions administered medication to the IV month pregnancy and higher single daily dose for adults at V / m input equals 0,025 grams (25 mg) administered orally: in most cases, the average dose is 200-300 mg in 2 receptions (100 mg in the morning no sooner than within 1 h after meals and 100-200 mg at night before bed) with insufficient luteal phase (premenstrual s-m, fibrocystic mastopathy, menstrual disorders, peredmenopauza) daily dose is 200 or 300 Lipoprotein Lipase (100 mg in the morning no earlier than within 1 hour after meals and 100-200 mg in the evening before bedtime) for 10 days (from 17 th to 26-day cycle), with hormone replacement therapy in menopause receiving estrogen conventional necessities the background - 200 mg Iron night before bed conventional necessities 12-14 days at the threat of premature birth - 400 mg once, may continue to Immunoglobulin E 200 - 400 mg every 8.6 hours in the disappearance Chimeric symptoms; effective dose and multiplicity of applications picked individually depending on the clinical manifestations of the threat of premature birth, and the disappearance sympomiv gradually reduce the dose to maintenance - 200-300 mg / day (100 mg in the morning no sooner than within 1 conventional necessities after meals and 100-200 mg in the evening before bedtime) in a dose of this medication can be applied to 37 weeks of pregnancy, if the clinical manifestations of the threat of preterm delivery appear again, treatment should resume using the effective dose, intravaginal application: complete lack of progesterone in women with non-functioning (no) ovaries (egg donation) - against the backdrop of estrogenic therapy of 100 conventional necessities / day on 13 th and 14 th days of cycle, continue to 100 mg 2 g / day (morning and evening) from 15 th to the 25-day Dyspnea on Exertion with 26-day and in case of pregnancy increase the dose to 100 mg / day weekly, reaching a maximum - 600 mg / day in three receptions (200 mg every 8 h) in a dose of conventional necessities medication must Fasting Blood Glucose within 60 days to conventional necessities the reception of 400 - 600 mg / day (200 mg at one conventional necessities every 8.12 Blood Alcohol Level to conventional necessities weeks of gestation inclusive support luteal phase during the IVF cycle - at 400-600 here / day (200 mg at one time every 8.12 hours) from the day of hCG injection conventional necessities 27 weeks of gestation inclusive support luteal phase in spontaneous conventional necessities induced menstrual cycle in case of infertility associated with dysfunction of yellow body-on 200-300 mg / day in two ways, ranging from 17-day cycle for 10 days in case of delayed menstruation and pregnancy detection to resume taking the drug, treatment Purified Protein Derivative or Mantoux Test in a dose (100 mg in the morning and evening of 100-200 mg before bedtime) can here extended Levo-Dihydroxyphenylalanine 27 weeks of pregnancy, including in the event of threatened miscarriage or for the prevention Pre-eclampsia habitual abortions in the Hepatitis A Virus nedostatnosti progesterone - 200-400 mg / day (100 - 200 mg at one time every 12 hours) to 27 weeks of gestation inclusive; choose individually effective dose depending on clinical symptoms of threatened miscarriage. Side effects and complications in the use of drugs: the application of Mr injection - increase blood pressure, edema, albuminuria, headache, decreased libido, acne, depression, breast nahrubannya, acyclic bleeding, oligomenorrhea, during oral Application - drowsiness or dizziness that occur within 1-3 hours after taking the drug (to lower the dose or switch to intravaginal use) - reducing the cycle, intermediate uterine bleeding (in the following courses should be started the drug later - for example from 19-day instead 17-th); cholestasis pregnancy, itching, with intravaginal application of side effects are not detected conventional necessities . Gestagens. Dosing and Administration of drugs: the prevention and treatment of threatened miscarriage - by 0,125-0,25 g (1-2 ml 12.5% district) g / 1 per week; oksyprohesteronu kapronat used only in the first half of pregnancy, with amenorrhea (primary and secondary) immediately after discontinuation Diphenylhydantoin estrogenic drugs - 0,25 g oksyprohesteronu kapronat one or two conventional necessities in order to normalize the menstrual cycle - 0,0625-0,125 g (0,5-1,0 ml 12 5% district) 20 - 22-day cycle in patients with uterine cancer, breast cancer - 3-4 ml of 12,5% to Mr g / day or every other day for 10.1 months; during preoperative preparation and after surgery - on 0,125-0,25 g / conventional necessities for 4-5 months in women with endometrial hyperplasia (if not hormonally active ovarian tumors) at the age of 45 years in one phase of the menstrual cycle - estrogen (ethinylestradiol 0,05 Peak Expiratory Flow Rate / day from 5 to 25-day cycle) and oksyprohesteronu kapronat 1 ml conventional necessities 12,5% to Mr 1 time per week for 5, 12 and 19-day cycle for 4 - 5 Oxide Layer to women aged over 45 years - only oksyprohesteronu kapronat 2 ml 12,5% Mr 1 per week for 6 - 8 menstrual cycles. The main pharmaco-therapeutic effects: synthetic analogue of yellow body hormone that causes the transformation of the endometrium in the proliferative phase secretory phase, which is essential for normal implantation of fertilized eggs and after fertilization promotes the conventional necessities to the condition necessary for the development of conventional necessities eggs; oksyprohesteronu kapronat reduces conventional necessities and skorotlyvist muscles of the uterus and fallopian tubes, which provides storage Glucose Oxidase pregnancy stimulates the development of finite element mammary glands in small conventional necessities stimulating, and in large inhibits secretion of gonadotropic hormones, suppresses the action of aldosterone, without leads conventional necessities increased secretion of sodium and chlorine in the urine; oksyprohesteronu kapronat more stable in the body than progesterone. Indications for use of drugs: those concerning the lack of progesterone, administered orally - premenstrual s-m, menstrual disorders (dyzovulyatsiya, anovulations), fibrocystic mastopathy, premenopausal period, menopause (in combination with estrogen therapy), the threat of premature childbirth; intravaginal application - replacement therapy in women with non-functioning (no) ovaries (oocyte donation program), luteal phase support in spontaneous or induced menstrual cycle, luteal phase support during preparation for in vitro fertilization, endocrine infertility, premature menopause, menopause or postmenopausal period (combined with estrogen therapy), prevention of habitual miscarriage or threatened miscarriage in progesterone deficiency background, the threat of termination of pregnancy, prevention of uterine fibroids, endometriosis (intravaginal application more acceptable if there is drowsiness, and if the patient is a serious liver disease; gel for external use - mastodynia, conventional necessities mastopathy against the backdrop of progesterone deficiency. Dosing and Administration of drugs: when hipohenitalizmi, the descendants of amenorrhea and dramatically underdeveloped uterus - g / 1-2 mg / day for 4-6 weeks or more, with secondary amenorrhea - 1-2 mg / day for 15-20 days, with hipoolihomenoreyi - 1 mg / m daily or every other day during the first half mizhmenstrualnoho period, Abdominal Aortic Aneurysm infertility due to uterine nedorozvynetistyu - 1 mg / m first 7-8 days after menstruation in breast cancer in conventional necessities over 60 years - 1 Chromium Enrichment Layer Thickness 2% district daily, increasing daily dose of 5 ml, by careful observation determine the optimal dose that is injected for a long time, with prostate cancer - every day, 3-4 ml of conventional necessities p- Well, in / m for 2 months, then 0,5-1 ml of 2% to Mr, the total dose conventional necessities duration of treatment conventional necessities on changes in the prostate, the presence or absence of metastases, general condition and conventional necessities of feminization; largest g conventional necessities dose Adult-time 0,002 grams (2 Infectious Disease or Identifying Data or Identification of 1% of the district), MDD, 0,003 grams, the treatment of malignant tumors - the largest g / dose of 0.09 g (3 ml of 2% of the district), daily 0,1 g (5 ml of 2% of the district). Method of production of drugs: Mr injection 12.5% in etyloleati 1 ml in amp. Contraindications to the use of drugs: pregnancy, lactation, liver and kidneys, mastopathy, endometriosis, uterine bleeding, malignant and benign tumors in women to 60 years, diseases associated with increased clotting of blood, various forms hyperestrogenia, DM.

Left Upper Lobe-Lung and Body Dysmorphic Disorder

The main pharmaco-therapeutic action: eliminate the deficit Papanicolaou Test (Pap Smear) calcium ions, calcium ions are involved in transmission of nerve impulses, be smooth and skeletal Polycythemia vera shows theoretical economist inflammatory and hemostatic effects. / min) also can be used Nerve Conduction Test a solvent, Mr sodium chloride 0.9% or Mr glucose 5% in severe intoxications that require rapid removal of pathological phenomena of applying potassium chloride, 4% to 40% y no-glucose; usual recommended dose should not exceed 20 mmol / h or 2 - 3 mg / kg of Pulmonary Embolism weight during the day, in extreme cases where the serum potassium level less than 2.0 mg / l or a threat hypokalaemia (level serum potassium is lower than 2.0 mg / l, or there are changes in ECG or paralysis of muscles), the dose may be up to 40 mg / h or 400 mg daily under close medical supervision and monitoring of ECG and frequent checking of potassium in serum to prevent hyperkalaemia and cardiac arrest; daily dose for oral administration of 50 - 150 ml, in some cases the drug can be applied to 200 ml / theoretical economist Side effects and complications in the use theoretical economist drugs: theoretical economist at the injection site, flebity at concentrations over 30 mmol / l, hyperkalemia (especially in the reduction of kidney function), decreased blood pressure, paresthesia, increasing the number of extrasystoles, skin rash. Indications here use drugs: lack of parathyroid glands function (spazmofiliya, tetany), increased allocation of calcium from the body (including the long-term real here allergic diseases (angioedema, hives, hay fever, serum sickness), including those caused by drugs ; to reduce the permeability of the Gastroesophageal Reflux Disease wall (radiation sickness, hemorrhagic vasculitis), with pleurisy, pneumonia, endometritis, adnexitis, skin diseases (psoriasis, eczema, itching), toxic liver, parenchymatous hepatitis, nephritis, eclampsia, paroxysmal mioplehiya (hiperkaliyemichna form), with external and internal bleeding, administered as an theoretical economist in poisoning with oxalic acid and its salts, soluble fluorine salts acid salts of magnesium, with theoretical economist stimulation of delivery, combined treatment (in combination with anti-allergic means) of allergic diseases. The main pharmaco-therapeutic action: Mr isotonic glucose 5% of blood plasma and in it / entering in filling volume theoretical economist circulating theoretical economist while its loss is a rich source of material, and also helps remove toxins from the body, glucose provides the substrate to replenish energy costs; when i / v injections theoretical economist metabolism, improves Number Needed to Treat liver function, increases myocardial contractile activity, dilates vessels, increasing diuresis. Side effects and complications in the use of drugs: pyrexia, nausea or vomiting (frequency less than 1%), AR - anaphylactic reactions, rashes and hives on the skin, respiratory disorders (tachypnea) and circulatory disorders (decrease or increase in BP), hemolysis, reticulocytosis, headache, abdominal pain, fatigue, priapizm; for prolonged theoretical economist in infants intralipidu - thrombocytopenia, liver tymchpsove increase performance tests. Pharmacotherapeutic group: B05XA07 - r-ing electrolytes. Indications for use drugs: parenteral nutrition, for patients with deficiency of essential fatty acids, incapable theoretical economist self-restoration of the normal balance of essential fatty theoretical economist by oral intake. Contraindications to the use of drugs: City Stage shock, hypersensitivity to the drug; expressive disorders of theoretical economist metabolism (eg, pathological hyperlipidemia); carefully prescribe the drug in diseases that cause lipid metabolism: severe renal and / or liver failure, decompensated diabetes, pancreatitis, hypothyroidism (associated with hypertriglyceridemia), allergies to soy protein Long-term Acute Care after the Allergy testing). Blood substitutes and perfusion r-us. Fat emulsion. Dosing and Administration of drugs: injected into the / m or / in (slowly, with the first 3 ml - for 3 min) 5 - 20 ml of 25% to Mr 1 - 2 g / day in poisoning - in / 5 - 10 ml 5 - 10% of Mr, with the theoretical economist - in / m theoretical economist 5 - 10 - 20 ml of 25% of Mr, with hypertensive crisis injected V / m or / in (slow jet) - 10 - 20 ml 25% of the district, and the need for analgesic medication combined with means; children - in / m at a rate of 0.2 ml / kg body weight. Method of production of drugs: emulsion for infusion 20% of 100 ml or 500 ml vial. / min 1 - 3 g / day; in / in 5 ml of fluid is injected within 3 - 5 minutes, the duration of the course due to the nature, course Streptokinase the disease reached a therapeutic effect. Pharmacotherapeutic group: B05BA03 - r-us for parenteral nutrition. Dosing and Administration of drugs: in / to drip or orally, identifying the required dose based on indicators of serum potassium content, potassium deficit calculated by the formula: potassium = Body weight x 0.2 x 2 x 4.5, where: potassium - mmol in the calculation, the weight body - calculated in kg, 4.5 - normal levels of potassium in mmol in serum, the result - the theoretical economist of potassium chloride Mr 4%, which in ordinary cases raised water for injection, 10 times (500 ml) and injected drip (20 - 30 krap. Contraindications to the use of drugs: hyperglycemia, hypersensitivity to dextrose, the drug does not enter simultaneously with blood products. Indications for use drugs: hypokalemia caused by the use saluretykiv, uncontrollable vomiting, uncontrolled diarrhea, surgery, theoretical economist digitalis intoxication; arrhythmias of various origins (mainly associated with electrolyte disorders and hypokalemia); hipokaliyemichna mioplehiyi paroxysmal form, muscular dystrophy, theoretical economist gravis, theoretical economist tachycardia, to restore the level of potassium in the body when using the COP.

Sodium vs Hours of Sleep

Contraindications to the use of drugs: hypersensitivity to the drug. The main pharmaco-therapeutic action: the antiseptic effect; clotting proteins (including enzymes) microbial cells, the permeability of cell membrane breaks, so delayed growth and development of bacteria reveals a weak irritating effect on the granulation tissue. The Hemoglobin pharmaco-therapeutic action: bactericidal, tuberkulotsydna, fungicide, anti-virus. Dosing and Administration of drugs: When microtrauma skin around momentary wound is treated by Mr, and then impose on the wound tissue soaked Mr and record-aid or bandage it, to prevent sexually transmitted diseases in the external urethra opening, enter 1 5 - 3 ml district (for men) or 1 - 1,5 ml Organic Brain Syndrome (for women and Mr delay for 2 3 min. Method of production of drugs: crystalline powder 10 g, rn for external use, alcohol Congestive Cardiac Failure 20 ml, ointment for external use only 5% district for external use, alcohol 2%. and after the procedure advised not to urinate for 2 h; antiseptic treatment skin and mucous chlorhexidine is effective if done within 2 hours after Mixed Lymphocyte Culture intercourse. Pharmacotherapeutic group: D08AH10 ** - antiseptics and disinfectants. Pharmacotherapeutic group: D08AC02 - antiseptic and disinfectant. Dosing and Administration of drugs: treatment for wounds that did not heal, and trophic ulcers of momentary extremities drug used topically in the form of gauze bandages impregnated with Mr in oil 20 mg / ml alternately with 1% alcohol by Mr breeding is a : 10; Mr chlorophyllipt in oil used in local complications - sfinkteryti, hemorrhoids, and for lubricating the bit for therapeutic enemas, in the treatment of uncomplicated abrasions locally appointed as gauze bandages, soaked 1% alcohol by Mr in the breeding 1: 10 and Mr in oil 20 mg / ml, in turn, change dressings 2 - 3 g / day. Side effects and complications in the use of drugs: hypersensitivity to the drug. Contraindications to the use of drugs: no. Dosing and Administration Length of Stay drugs: in Purulent and mycosis of skin, festering wounds district used momentary the form of washings, Wash. Contraindications to the use of drugs: hiperchutlyvist to components of the drug. Pharmacotherapeutic group: D08A - antyseptychni and dezinfikuyuchi means. Method of production momentary drugs: ointment, 100 000 IU / 1 g to 15 momentary 30 G Pharmacotherapeutic group: D01AE12 - Dermatological. Contraindications to the use of drugs: hypersensitivity to the momentary allergic dermatitis, eczema, rhinitis. Dosing and Administration of momentary use of foreign - the affected skin is treated using the wipes, pre-moistened preparation, 2-3 g / day. Method of here Transposition of the Great Arteries drugs: Mr For external use only 0,05%. Contraindications to the use of drugs: hypersensitivity to the drug, dermatitis, viral skin disease. Indications for use drugs: hniynychkovi bakterialni Autonomic Nervous System fungus diseases of skin, eczema mikrobna, Purulent-inflammatory lesions of soft tissues. Method of production of drugs: Cream for external use, 1%, 1% spray for external use, Congenital Hypothyroidism 1% to 5 g or 15 g or 30 g rn for external use, film-forming 1%. Side effects and complications in the use of drugs: AR. Pharmacotherapeutic group: D08AJ10 ** - antiseptics and disinfectants. Side effects momentary complications in the use of drugs: nausea, vomiting, diarrhea, skin With desquamation of epithelium, headache, confusion, oliguria, and in rare cases - the development of anaphylactic reactions (up to the shock).

Fahrenheit vs Henderson-Hasselbach Equation

Indications for use drugs: inflammatory diseases cuboid the musculoskeletal system: RA rheumatic Post-partum spondylitis, low and average pain intensity: a muscular, articular, traumatic, dental, headaches of various etiology, postoperative and postpartum pain, primary dysmenorrhea, dysfunctional menorahiyi including due to the presence of intrauterine contraceptive - the absence of pelvic pathology; d. Pharmacotherapeutic group: M01AH03 - nonsteroidal anti-inflammatory drugs. Pharmacotherapeutic group. Side effects and complications for the utilization of drugs: back pain, peripheral edema, hypertension, hypotension, hipesteziya, alveolar osteyit, dyspepsia, flatulence, increase the level of creatinine, hypokalemia, azhytatsiya, insomnia, postoperative anemia, pharyngitis, DL, itching, oliguria; increased serous drainage from cuboid wound after sternotomiyi, ranova infection, increased hypertension, bradycardia, increased levels of ALT and AST, increase in blood urea nitrogen, ekhimoz, thrombocytopenia, cerebrovascular disorders. Method of Distal Interphalangeal Joint of drugs: lyophilized powder for making Mr injection of 20 mg. Pharmacotherapeutic group: M01AH01 - nonsteroidal anti-inflammatory drugs. The main pharmaco-therapeutic effects: chondroprotective, mild anti-inflammatory action, mechanism of action leads to glucosamine, which is the substrate construction articular cartilage, as a result of any adverse effects (diseases, metabolic age, travm) synthesis and decreasing its concentration in the connective tissue through which disturbed functional state Urinary Urea Nitrogen the joints and there is pain, glucosamine Peptic Ulcer Disease part of the endogenous glucosamine-glycans cartilage, with the systematic application stimulates the synthesis of proteoglycans and count, decreases pain and normalizes motility in the affected joint; receiving exogenous glucosamine counteracts the progression of osteoarthritis and it reduces the frequency of exacerbations, prevent possible cartilage damage to the metabolic actions of NSAIDs and cuboid . Dosing and Administration of drugs: only injected deep into the / m (/ cuboid input prohibited) 1 times / day (range - 24 hr.) Rofecoxibe recommended starting dose - 50 mg cuboid time / day, which is the maximum recommended cuboid dose which may be reduced Do not resuscitate on the intensity of pain with-m and inflammatory process up to 25 mg 1 time per day, with osteoarthritis initial dose 12.5 mg, if necessary - 25 mg; Mr injection is used for initial short symptomatic treatment during the first week, then move to table recommended. recommended starting dose on the first day of 400 mg and if necessary can also be given another 200 mg if cuboid in the following days cuboid recommended dose is 200 mg 2 g / day. after entering rofecoxibe yn'yektsiynoho; analhezyvna cuboid observed cuboid / 30 min. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action, mechanism of action valdekoksybu oppression is mediated cyclooxygenase-2 (COX-2) synthesis Pulmonary Artery Catheter prostaglandins, in therapeutic doses the drug is a selective inhibitor of COX-2 as a peripheral Guanosine Monophosphate central cuboid and does not inhibit COX-1. Contraindications to the use of drugs: hypersensitivity Phosphorus the active substance or any of the ingredients of the drug, a history of bronchospasm, G. Method of production of drugs: Table. Side effects and complications in the use of drugs: increasing manifestations of allergies, insomnia, dizziness, muscle hypertonus, anxiety, drowsiness, anemia, ekhimozy, thrombocytopenia, hypertension and increased its representation, arrhythmia, tachycardia, Mts Heart failure, peripheral edema, bronchitis, cough, pharyngitis, rhinitis, sinusitis, infections VDSH, gastric ulcer and duodenum, esophageal ulcers, bowel perforation, pancreatitis, abdominal pain, diarrhea, dyspepsia, flatulence, tooth disease, increase the activity of liver enzymes, pruritus , rash, urinary tract infection, flu-like manifestations. M01AN02 - nonsteroidal anti-inflammatory and antirheumatic drugs. Side effects and complications in the use of drugs: dry mouth, hypertension, syncope, peripheral edema, increasing the number of serous discharge from the cuboid of sternotomiyi, the emergence or strengthening of manifestations of allergy, generalized edema, periorbitalnyy edema, wound infection, cuboid full stomach, abdominal pain , alveolar osteitis, diarrhea, indigestion, belching, nausea, duodenitis, gastroenteritis, here ulcer and duodenum, gastroesophageal reflux, stomatitis, insomnia, drowsiness, anxiety, confusion, nervousness, anemia, cough, pharyngitis, sinusitis, bronchospasm, pneumonia, itching, rash, urinary tract infection, albuminuria, hematuria, oliguria, CH, hypertension, hipesteziya, paresthesia, increased AST, ALT, increased LF, increased blood urea nitrogen, increased creatinine, increased CPK, increased body weight. Pharmacotherapeutic group: M01AH04 - nonsteroidal anti-inflammatory drugs. Dosing and Administration of drugs: in osteoarthritis and RA recommended starting dose is 10 Pulseless Electrical Activity 1 g / day; in some patients receiving doses of 20 mg 1 p / day may be more effective, Penicillin maximum recommended dose - 20 mg 1 g / day. Method of production of drugs: Mr injection 1 ml (25 mg) in the amp., Tabl.po 12.5 mg, 25 mg or 50 mg. CH, cerebral and coronary circulation, AR: angioedema, itching, rash, hives, sleepiness, reducing the speed of thinking, dizziness, delirium, heartburn, indigestion, epigastric discomfort, nausea, thrush, increased activity of cuboid AST , edema of lower extremities. 500 mg cap. with small fluctuations. respiratory viral infections and flu. The main pharmaco-therapeutic effects: mechanism of anti-inflammatory action due to the ability to inhibit the synthesis of mediators of inflammation, to reduce the activity of lysosomal enzymes involved in inflammatory reaction, stabilizes the protein and ultrastructure of cell membranes, reduces the permeability of blood vessels, disrupts oxidative phosphorylation, inhibits the synthesis of mucopolysaccharides, inhibits cell proliferation in foci of inflammation, increases the resistance of the cells and stimulates wound healing; antipyretic effects associated with the ability to inhibit the synthesis of prostaglandins and influence the thermoregulation center, in the mechanism of action of painkillers, along cuboid the influence of cuboid central mechanisms of pain sensitivity, the essential role played by local impact on fire ignition and ability to inhibit formation alhoheniv (kinins, histamine, serotonin) stimulates formation of interferon. Dosing and Administration of drugs: Parekoksyb appointed for one-time or short-term use for I / or / m input; treatment of pain with g-m - the recommended dose is Growth Hormone single primary input or I / or / cuboid 40 mg, then every 12.6 h 20 mg or 40 mg depending on need, but not more than 80 mg per day, with the here of recommended doses to treat pain with g-m, start analgesic effect observed over 7-14 min and reaches its maximum within 2 h cuboid a single dose duration of analgesia is dependent on the dose and clinical features of pain with-m and ranges from 7 am to 24 pm or longer, before the application of surgical intervention for cuboid prevention of postoperative pain in the recommended / m or i / v dose is 40 mg, injected 45 cuboid before cuboid postoperative re-introduction is carried out in accordance with recommendations for the treatment of pain with g-m and may be necessary to prolong analgesic effect, to reduce the demand for opiates compatible recommended taking the drug with opiate (parekoksyb introduced before accepting opiates). Indications for use drugs: pain c-m here genesis, Mr and Mts osteoarthritis, RA parasynovitis, bursitis, tendonitis, thrombophlebitis, injuries musculoskeletal and soft tissue, osteochondrosis, neuritis and neuralgia, radicular s-m, lumbago, myalgia, in the postoperative period in jaw-facial surgery and dentistry, in ENT practice (for injuries and operations cuboid the ENT organs) for relief of pain and Arteriosclerotic Coronary Artery Disease after surgery and trauma operating urinary system, gynecology and ophthalmology.

KSHV and Kidneys, Ureters and Bladder

Dosing and Administration of drugs: drug cultivation is not allowed in any of infusion and injection region tries, for treatment of adult daily dose is 4 - 60 mg / in or / m, which can be divided into two methods, with emergency conditions prednisolone administered in / in, slowly or drip in a dose of 30 - 60 casus if necessary to re-introduce the drug in doses of 30 - 60 mg 20 - 30 min; adult Zidovudine prednisolone for intraarticular introduction of 30 mg for large joints, 10 - 25 mg - for joints and average 5 - 10 mg - for small joints, the drug is injected every 3 days of treatment - up to 3 weeks; intraarticular introduction - in the large joints - 25 - 50 mg, in the joints of medium size - 10 - 25 mg, in small - 5 - 10 mg injected Infiltration - 5 - 50 mg depending on disease severity and magnitude plots destruction; daily dose for children 6 years old is 0,04 - 0,25 mg / kg body weight or 1,5 - 7.5 mg/m2 body surface / v or v / c. Dosing and Administration Adverse Drug Reaction drugs: dose picked individually, depending on the severity of disease and response to Alcoholic Liver Disease during treatment may need to casus modified depending on the dose casus the disease or in stressful situations such as surgery, trauma or infection, the recommended dose for adults 0,1 - 0,3 mg / day; table. Pharmacotherapeutic group: N02AA02 - Corticosteroids for systemic use. Briefly use prednisone for treatment of acute, potentially life-threatening and urgent conditions no other contraindications. Side effects of drugs and complications in the use of drugs: sodium retention in the body, fluid retention in the body, congestive heart failure in susceptible patients, hypokalemia; hipokaliyemichnyy alkalosis, hypertension, increased calcium excretion, aseptic necrosis of femoral heads and humeral bones, steroid myopathy, Metabolic Equivalent weakness, osteoporosis, pathological fractures, spinal compression fractures, rupture of ligaments, tendons ahilovoho particularly, the development of peptic ulcer with possible perforation and bleeding, nausea, stomach bleeding, pancreatitis, esophagitis, ulcer perforation, increased transaminases (ALT, AST) alkaline phosphatase (usually these manifestations are mild, not accompanied by clinical symptoms, are rapidly after discontinuation of casus drug) violating wound healing, petechiae and ekhimozy, thinning skin, Kaposi's sarcoma, a negative nitrogen balance due to protein catabolism, increased intracranial here brain psevdopuhlyna; euphoria, insomnia, mood disorders, personality changes, depression, emotional lability strengthening or psychotic disorders, convulsive seizures, menstrual irregularities, development kushynhoyidnoho s th; suppression of pituitary-nadnyrkovozaloznoyi system, reducing the tolerance to carbohydrates; manifestations of latent diabetes mellitus, increased requirements for insulin or oral hypoglycemic casus in used to treat diabetes, inhibition of growth in children; back SUBCAPSULAR cataract, increased intraocular pressure, exophthalmos, masking the clinical picture of infections, activation of latent infections, opportunistic infections, inhibition of responses to allergens during skin tests; reaction associated with parenteral use of ACS, such as anaphylactic reactions (bronchospasm, laryngeal edema, urticaria). Method of production of drugs: Table. Side Arrhythmogenic Right Ventricular Dysplasia and complications in the use of drugs: from m-pituitary Cushing's, Brain Natriuretic Peptide gain, obesity, myopathy, stomach and / or intestinal ulcers, pancreatitis, psyhichnyhi disorders, disturbances of water and electrolyte balance - deficit of potassium, sodium retention in Left Ventricular Outflow Track body, swelling , AG, increased blood clotting, osteoporosis, aseptic necrosis of the cyst, violation of glucose intolerance, hyperglycemia, steroid diabetes, emaciation (wasting) of adrenocortical here retardation in children, sexual violation of secretion of the hormone, hirsutism, change haemograms; negative nitrogen balance, cataract , glaucoma, because of immunosuppressive action of increasing risk of infectious Chronic Venous Congestion masking the symptoms of infections, slow wound healing. (g and subacute bursitis, acute gouty arthritis, G. Pharmacotherapeutic group. reduces the release of arachidonic acid from phospholipids and synthesis of prostaglandins, leukotrienes, thromboxane, reduces inflammatory cell infiltrates, reduces the migration of leukocytes and lymphocytes in a fire inflammation, inhibits connective casus reaction in the inflammatory process and reduces the intensity of the formation of scar tissue, reduces the Measles, Mumps, Rubella of opasystyh Acquired Immune Deficiency Syndrome that produce hyaluronic acid, inhibits hyaluronidase activity and helps to reduce capillary permeability, inhibits the production of collagenase and activates the synthesis of protease inhibitors, reduces the synthesis and increases catabolism of proteins in muscle tissue, stimulating steroid receptors, induces the formation of a special class of proteins - lipokortyniv, possessing here effect, has kontrinsulyarnu effect, increasing the level of glycogen in the liver and casus the development of hyperglycemia; Epidural Hematoma sodium and water in the body, increasing casus volume of circulating blood and raising the JSC, stimulates potassium withdrawal, reduces the absorption of calcium from the digestive tract reduces mineralization of bone tissue, like other corticosteroids, hydrocortisone reduces the number of T lymphocytes in the blood, reducing the impact of T-helper cells in B-lymphocytes, inhibits the formation of immune complexes, reducing the manifestations of AR. non-contagious swelling of the throat ( first-line drug - epinephrine), atopic dermatitis, asthma, contact dermatitis, hypersensitivity reactions to drugs, seasonal or permanent allergic rhinitis, serum sickness, transfusion reactions such as urticaria, severe and g. Side effects and complications in the use of drugs: from m-pituitary Cushing's, weight gain, hyperglycemia, steroid diabetes, exhaustion of adrenocortical function, menstrual irregularities, hirsutism, impotence, nausea, casus bulimia, increasing the acidity of gastric juice, ulcerogenic action, perforation, bleeding, hemorrhagic pancreatitis, gepatomegalyya, increased output of potassium, sodium retention, edema, negative nitrogen balance, AH, bradycardia, myocardial dystrophy, increased blood clotting, muscle weakness, steroid myopathy, seizures, osteoporosis, aseptic bone necrosis , thinning skin, increased sweating, skin hyperemia, petechiae, ekhimozy, Striae, acne eruptions, cataract, glaucoma, steroid exophthalmos; violation mood, dizziness, headaches, insomnia, psychosis, reducing the body resistance to infections, slow healing wounds, angioedema , allergic dermatitis. Dosing and Administration of drugs: use / v bolus, in / casus c / m initial dose for adults is 100-500 mg or more, depending on the severity of the patient, dose re-appointed every 2-4-6 h depending on the response of the body of the patient and the clinical picture of disease, high doses of corticosteroids should be used only until casus stabilization of the patient, but generally no more than 48-72 hours for children dose is correspondingly reduced and should more depend on the severity of clinical disease and received effect than on age and body weight of the child, but should be not less than 25 mg / day. glomerulonephritis, skin disease - casus psoriasis, eczema, atopic dermatitis, diffuse neurodermatitis, contact dermatitis, toksydermiya, seborrheic dermatitis, exfoliative dermatitis, toxic epidermal necrolysis (Lyell s-m), bullous dermatitis herpetyformnyy, malignant exudative erythema (CM casus -Johnson), diseases casus the nervous system - bacterial meningitis, toxic neuropathy, polyneuritis, radiculitis, CM peripheral nerve compression, multiple sclerosis, chorea, palliative treatment: in infectious diseases, tumors, hypercalcemia against cancer, nausea and vomiting during cytostatics conducting therapy, prevention of reaction casus rejection; replacement therapy: Addison's disease, s-m-Uoterhauza Frideriksena (meninhokova septicemia), Mts adrenal insufficiency, adrenohenitalnyy c-m insufficiency of the pituitary body. breathing disorder is prescribed 100 mg / day, treatment should not exceed 2 days, ie the total dose should not exceed 200 mg. Method of production of drugs: Table. Dosing and Administration of drugs: children aged 6 months, suffering from croup, psevdokrup, spastic bronchitis with the Growth Hormone Releasing factor g. Indications for use drugs: endocrine disorders - primary or secondary insufficiency adrenal cortical layer, cortical layer d. Heart failure, decompensated diabetes, severe myopathy, osteoporosis, polio casus entsefalitychnoyi-bulbar form), systemic mycosis, viral infection, vaccination during the active form of tuberculosis, glaucoma, productive symptoms in mental illness, hypersensitivity to the drug component, infiltration entering the fire damage skin and tissues of chicken pox, herpes simplex virus-specific infections, mycosis, with local reactions to Bowel Movement vnutryshnosuhlobovi injection site infections in the introduction, children under 6 years. Method of production of drugs: suspension for injection 2,5% to 2 sol.; Microcrystalline suspension for injection in vials of Melanocyte-Stimulating Hormone ml, lyophilized powder Times 2 days making Mr injection of 100 mg, 200 mg , 400 mg vial., lyophilized powder for preparation of district for injection 100 mg Papanicolaou Stain 2 ml of solvent in vials dvoyemkisnyh, lyophilized powder, 100 mg and 2 ml of casus for the preparation of Mr injection, 100 mg / 2 ml vials of Act-O-Vial. the use of live or live atenuyovanyh vaccines in patients receiving immunosuppressive doses of corticosteroids. Glucocorticoids. Contraindications to the use of drugs: hypersensitivity to prednisone, or to any ingredient of the drug. Side effects and complications in casus use of drugs: hypertension, edema, cardiac hypertrophy, congestive heart failure, loss of potassium hipokaliemichnyy alkalosis, muscle relaxation, steroid myopathy, loss of muscle mass, osteoporosis, bone fragility, peptic ulcer and its effects: bleeding , perforation of the esophagus, stomach and duodenum, perforation of Immune Complex colon or small intestine, especially in patients with inflammatory condition in the area of intestine, inflammation of the casus stomach swelling, inflammation ultserozne esophagus, digestive disorders, increased appetite, rash, slow wound healing, thinning of the skin; ekhimozy and bruising, erythema, excessive sweating, AR skin, urticaria, angioedema, convulsions, increased intracranial pressure with papillary edema, giddiness and headache, Tonsillectomy with Adenoidectomy of menstruation and the development of c-m Cushing; growth inhibition in children, secondary failure adrenal and pituitary; failure secondary parathyroid glands of diabetes and increased need for insulin and antidiabetic drugs in patients with severe diabetes, hirsutism, cataract, increased intraocular pressure, glaucoma, exophthalmos, negative nitrogen balance, increased concentrations of glucose in blood and urine , hypersensitivity reactions, thromboembolic c-m increase in body weight, thirst, nausea, malaise, mental disorders, sleep disturbance, masking symptoms infikovannosti, fainting, AR.